Transmission intensity and human immune responses to lymphatic filariasis

Parasite Immunology

Volumn 23, Issue 7, 2001, Pages 363-371

  King, Christopher L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basophils; Filarial nematodes; IL 4; Transmission intensity

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5;

ANTIGEN PRESENTING CELL; ARTICLE; BASOPHIL; BRUGIA PAHANGI; CELL FUNCTION; EXPOSURE; FILARIASIS; HUMAN; HYPERSENSITIVITY REACTION; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFECTION RISK; LARVA; LEUKOCYTE ACTIVATION; LYMPHATIC SYSTEM DISEASE; LYMPHOCYTE PROLIFERATION; MAST CELL; NONHUMAN; PARASITE TRANSMISSION; PRIORITY JOURNAL; WUCHERERIA BANCROFTI;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; BASOPHILS; BRUGIA MALAYI; ELEPHANTIASIS, FILARIAL; HUMANS; HYPERSENSITIVITY, IMMEDIATE; LYMPHOCYTE ACTIVATION; TH2 CELLS; WUCHERERIA BANCROFTI;

BRUGIA PAHANGI; NEMATODA; WUCHERERIA BANCROFTI;

EID: 0034850181     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.2001.00395.x     Document Type: Article

References (67)

1. Regulation of the immune response in lymphatic filariasis and onchocerciasis
2. Expression of cross-reactive surface antigens by microfilariae and adult worms of Brugia pahangi during infections in cats
3. Cellular immune responses of jirds to extracts of life cycle stages and adult excretory secretory products during the early development of Brugia pahangi
4. The number and distribution of Brugia pahangi in cats at different times after a primary infection
5. The immunodeficient scid mouse as a model for human lymphatic filariasis
6. Studies on a filarial antigen with collagenase activity
7. Structural biology of allergens
8. Immediate hypersensitivity responses in the immunopathogenesis of human onchocerciasis
9. Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass
10. IgE responses in human filariasis. II. Qualitative characterization of filaria-specific IgE
11. IgE responses in human filariasis. IV. Parallel antigen recognition by IgE and IgG4 subclass antibodies
12. IgE responses in human filariasis. I. Quantitation of filaria-specific IgE
13. Immunoregulation in human lymphatic filariasis: The role of interleukin 10
14. Regulation of immune responses in lymphatic filariasis
15. Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset
16. IL-4- and IL-5-secreting lymphocyte populations are preferentially stimulated by parasite-derived antigens in human tissue invasive nematode infections
17. Differences in the frequency of cytokine-producing cells in antigenemic and nonantigenemic individuals with bancroftian filariasis
18. High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis
19. Antigen-stimulated IL-4, IL-13 and IFN-gamma production by human T cells at a single-cell level
20. Cytokine regulation of antigen-driven immunoglobulin production in filarial parasite infections in humans
21. Identification of recombinant filarial proteins capable of inducing polyclonal and antigen-specific IgE and IgG4 antibodies
22. Differential regulation of antigen-specific IgG4 and IgE antibodies in response to recombinant filarial proteins
23. Interleukin-12 suppresses immunoglobulin E production but enhances immunoglobulin G4 production by human peripheral blood mononuclear cells
24. Th1-Th2: Reliable paradigm or dangerous dogma?
25. Specific cellular immune unresponsiveness in human filariasis
26. Antigen-specific suppressor cells and suppressor factors in human filariasis with
27. Th1-like antifilarial immune responses predominate in antigen-negative persons
28. An analysis of in vitro B cell immune responsiveness in human lymphatic filariasis
29. Reduced antifilarial IgG4 responsiveness in a subpopulation of microfilaremic persons
30. The presence or absence of active infection, not clinical status, is most closely associated with cytokine responses in lymphatic filariasis
31. Immunologic tolerance in lymphatic filariasis. Diminished parasite-specific T and B lymphocyte precursor frequency in the microfilaremic state
32. Elevated IL-10 mRNA expression and down-regulation of Th1-type cytokines in microfilaraemic individuals with Wuchereria bancrofti infection
33. Immunological tolerance: The key feature in human filariasis?
34. Long-term effect of prenatal exposure to maternal microfilaraemia on immune responsiveness to filarial parasite antigens
35. Immunology taught by viruses
36. A novel member of the transforming growth factor-beta (TGF-beta) superfamily from the filarial nematodes Brugia malayi and B. pahangi
37. Effect of treatment with diethylcarbamazine on immune responses to filarial antigens in patients infected with Brugia malayi
38. Elevated cellular immune responses and interferon-gamma release after long-term diethylcarbamazine treatment of patients with human lymphatic filariasis
39. Modulation of the host response in human schistosomiasis. I. Adherent suppressor cells that inhibit lymphocyte proliferative responses to parasite antigens
40. Suppressive antigen-presenting cells in helminth infection
41. Anti-interleukin-4 modulation of the Th2 polarized response to the parasitic nematode Brugia pahangi
42. Interleukin-10 and antigen-presenting cells actively suppress Th1 cells in BALB/c mice infected with the filarial parasite Brugia pahangi
43. The L3 of Brugia induces a Th2-polarized response following activation of an IL-4-producing CD4-CD8-alphabeta T cell population
44. Requirement for in vivo production of IL-4, but not IL-10, in the induction of proliferative suppression by filarial parasites
45. Profound suppression of cellular proliferation mediated by the secretions of nematodes
46. Transmission dynamics of Wuchereria bancrofti in East Sepik Province, Papua New Guinea
47. Delayed-type hypersensitivity reactions to Onchocerca volvulus antigens in exposed and non-exposed African individuals
48. Suppression of human lymphocyte responses to specific and non-specific stimuli in human onchocerciasis
49. Cell-mediated and humoral immune response to tetanus vaccinations in onchocerciasis patients
50. Non-specific suppression of antigen-induced lymphocyte blastogenesis in Onchocerca volvulus infection in man
51. Specific T cell unresponsiveness in human filariasis: Diversity in underlying mechanisms
52. Filarial surface antigens: The major 29 kilodalton glycoprotein and a novel 17-200 kilodalton complex from adult Brugia malayi parasites
53. B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases
54. Immunomodulatory properties of a phosphorylcholine-containing secreted filarial glycoprotein
55. A filarial nematode-secreted product signals dendritic cells to acquire a phenotype that drives development of Th2 cells
56. Selective development of T helper (Th) 2 cells induced by continuous administration of low dose soluble proteins to normal and beta (2)-microglobulin-deficient BALB/c mice
57. Interleukin 4-producing CD4 T cells arise from different precursors depending on the conditions of antigen exposure in vivo
58. Prostaglandin D2 as a mediator of allergic asthma
59. The role of mast cells and basophils in immunoregulation
60. Histamine suppresses gene expression and synthesis of tumor necrosis factor alpha via histamine H2 receptors
61. Modulation of the host response in human schistosomiasis. IV. Parasite antigen induces release of histamine that inhibits lymphocyte responsiveness in vitro
62. Induction of human IgE synthesis in B cells by mast cells and basophils
63. Mechanisms and pharmacologic control of basophil-derived IL-4 and IL-13
64. Frequency and characterization of antigen-specific IL-4- and IL-13-producing basophils and T cells in peripheral blood of healthy and asthmatic subjects
65. The role of albendazole in programmes to eliminate lymphatic filariasis